• Publications
  • Influence
Fungal peritonitis in peritoneal dialysis: critical review of six cases.
Fungal peritonitis (FP) is uncommon in patients on peritoneal dialysis (PD); it is difficult to treat and has a high mortality rate. We report 6 cases of fungal peritonitis observed between 1980 andExpand
  • 22
  • 2
Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
Glucose absorption from peritoneal dialysis solutions causes a chronic stimulation of insulin secretion, which leads to hyperinsulinism. The use of solutions without glucose should correct thisExpand
  • 48
  • 1
Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis.
In 32 noncirrhotic patients on peritoneal dialysis, mean serum beta 2-microglobulin (s beta 2M) was 26.58 +/- 12.32 mg/l (9.7-63.5). We found a significant correlation between s beta 2M and serumExpand
  • 43
  • 1
Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
BACKGROUND AND PURPOSE The relationship between the radiation dose and the risk of the osteoradionecrosis is well known. However, the dose to the mandible is not routinely assessed in theExpand
  • 22
  • 1
Compliance Study in Peritoneal Dialysis Using Pdadequest Software
Poor compliance in peritoneal dialysis (PD) is a significant cause of dropout and morbidity. PD Adequest software, which, through a mathematical model, predicts the effect of the dialysisExpand
  • 13
  • 1
Calcium lactate interference in measuring creatinine in peritoneal dialysis fluids by the Jaffé kinetic method.
Creatinine measurements in peritoneal dialysis fluids using the Jaffé method have poor specificity due to interfering substances. We have checked to see if calcium lactate, in addition to glucose,Expand
  • 3
  • 1
Comparison of fast peritoneal equilibration tests with 1.36 and 3.86% dialysis solutions.
At present dialysis solutions with different glucose concentrations are used for the peritoneal equilibration test (PET) and Fast-PET in peritoneal dialysis (PD). We compared the results of twoExpand
  • 24
Continuous tidal peritoneal dialysis (CTPD) prescription and adequacy targets.
NKF-DOQI guidelines suggest a Kt/V value of 2.1 and a creatinine clearance (CRCL) value of 63 L/1.73 m2 of body surface area per week as minimum targets in continuous cycling peritoneal dialysisExpand
  • 18
Clinical Validation of PD Adeouest Software: Modeling Error Assessment
Objective PD ADEQUEST software (Baxter Healthcare, Deerfield, IL, U.S.A.) is used in peritoneal dialysis for calculating the indices of dialysis efficiency and for the mathematical simulation of theExpand
  • 19
Correction of glucose concentration interference on Jaffé kinetic creatinine assay in peritoneal dialysis.
Overestimation of creatinine measurement using the Jaffé kinetic method in peritoneal dialysis solutions, due to glucose interference, has been quantified and corrected through the elaboration ofExpand
  • 16